Biotech Values

[ilpapa]

We admittedly don't know what the final FDA decision on Lorca will be, but there have been multiple signals that the Agency looks on these drugs at least in some part as cosmetic drugs as much as meeting the medical need of obesity control. Hence a high safety bar. I had some VVUS but sold months ago because of this danger.

VVUS would have been a good short this afternoon. I had decided to wait until the end of trading, but by then it had already deflated, and might not even have been borrowable - labeled "Hard To Borrow" at Schwab.

Murphy must indeed be a thrill seeker.

(And if his daughter has inherited his brains, she can forget about applying to Harvard.)